Preoperative Hormone Therapy for Pre- and Postmenopausal Women With ER [estrogen receptor] Positive Breast Cancer: A Double Blind Randomized Parallel Group Phase II Trial, Comparing the Effect of 2 Weeks of Preoperative Estetrol With Placebo.

Trial Profile

Preoperative Hormone Therapy for Pre- and Postmenopausal Women With ER [estrogen receptor] Positive Breast Cancer: A Double Blind Randomized Parallel Group Phase II Trial, Comparing the Effect of 2 Weeks of Preoperative Estetrol With Placebo.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Sep 2014

At a glance

  • Drugs Estetrol (Primary)
  • Indications Early breast cancer
  • Focus Biomarker; Pharmacodynamics
  • Sponsors Pantarhei Bioscience
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 04 May 2012 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
    • 24 Mar 2012 Results presented at the 8th European Breast Cancer Conference.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top